Cutaneous Adverse Effects Common With Enfortumab Vedotin for Urothelial Cancer
Researchers described dermatologic events associated with the use of enfortumab vedotin in treatment of locally advanced/metastatic urothelial cancer.
Researchers described dermatologic events associated with the use of enfortumab vedotin in treatment of locally advanced/metastatic urothelial cancer.
Undergoing progressive relaxation exercise training improved management of distress, physical symptoms, and psychological symptoms in patients receiving chemotherapy for lung cancer.
Researchers identified patterns around usage of scalp cooling therapy to reduce the risk of chemotherapy-induced alopecia in patients.
Overall seroprevalence of measles and mumps antibodies 0.75 and 0.62 for ambulatory cancer patients.
Patients without comorbidities were less likely to undergo screening for colorectal cancer than patients with comorbidities.
Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.
A randomized trial sought to determine the effectiveness of electroacupuncture and auricular acupuncture in managing musculoskeletal pain in cancer survivors.
Retrospective study sought to determine incidence of pulmonary embolism after a diagnosis of subsegmental pulmonary embolism in patients with cancer.
The American Society of Hematology released guidelines for preventing and managing venous thromboembolism in patients with cancer.
Researchers identified the risk factors for chemotherapy-induced peripheral neuropathy in cancer patients treated with paclitaxel or oxaliplatin.